Abstract: The present invention relates to nanofibers. In particular, the present invention provides aligned nanofiber bundle assemblies. In some embodiments, the aligned nanofiber bundle assemblies are used for tissue regeneration, controlled growth of cells, and related methods (e.g., diagnostic methods, research methods, drug screening).
Type:
Grant
Filed:
February 14, 2008
Date of Patent:
July 8, 2014
Assignee:
Northwestern University
Inventors:
Samuel I. Stupp, Shuming Zhang, Alvaro Mata, Megan A Greenfield
Abstract: Disclosed herein are compositions, methods, and devices related to bilayer and monolayer membranes, their encapsulation in a hydrogel, and their formation. Methods of using the disclose compositions and devices are also disclosed.
Type:
Grant
Filed:
October 13, 2006
Date of Patent:
October 18, 2011
Assignee:
The Regents of the University of California
Inventors:
Jacob J. Schmidt, Noah Malmstadt, Tae-joon Jeon, Jason Poulos
Abstract: Solid Lipid Nanoparticles of platinum compounds, particularly of antitumor platinum complexes are disclosed. The Nanoparticles of the invention are obtained by a process comprising: a) preparing a first microemulsion by mixing a molten lipid, a surfactant, and optionally a co-surfactant and the platinum compound acqueous solution; b) preparing a solution by mixing a surfactant and optionally a co-surfactant in water, heating to complete solution, preferably at the same melting temperature of the lipid used in a) and adding a co-surfactant; c) dispersing the microemulsion obtained in a) into the solution obtained in b) obtaining a multiple microemulsion c); d) dispersing the microemulsion obtained in c) in aqueous medium at a temperature ranging from 0.5° C. to 4° C.
Type:
Grant
Filed:
March 24, 2005
Date of Patent:
November 3, 2009
Assignees:
Cell Therapeutics Europe S.r.l., NANOVECTOR S.r.l.
Inventors:
Maria Rosa Gasco, Paolo Gasco, Alberto Bernareggi
Abstract: The present invention is directed to nanoparticulate active agent compositions comprising lysozyme as a surface stabilizer. Also encompassed by the invention are pharmaceutical compositions comprising a nanoparticulate active agent composition of the invention and methods of making and using such nanoparticulate and pharmaceutical compositions.